Company intelligence / Profile preview
Zhejiang Jinhua CONBA Bio-Pharm
Jinhua, Zhejiang, Chinajhconba.com ↗
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
01
Overview
Zhejiang Jinhua CONBA Bio-Pharm has an extensive portfolio of approved APIs and finished drug products, including several anti-infectives, cardiovascular, and CNS agents, with ongoing clinical development primarily in small molecule and peptide modalities; several bioequivalence and Phase 1 trials are registered, and the company maintains regulatory compliance for international markets[1][3][5][11].
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyRheumatologyGastroenterologyInfectious DiseasesPulmonologyDermatologyPsychiatry
- Modalities
- Small moleculeSynthetic peptide
- Industry
- Pharma
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
EVA Pharma (strategic supply agreement for global healthcare supply chain resilience and access)[6]
Beyond the preview
Go deeper on Zhejiang Jinhua CONBA Bio-Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Jinhua CONBA Bio-Pharm.